Drug Law Weekly

China Medical University, Taichung - Novel assay screens anti-SARS drugs

Cordis Corporation - Cypher stent trial yields positive results for diabetics with heart disease

Cornell University - Chimera of lutropin receptor and chorionic gonadotropin subunit developed

Cornell University - OspA protein of Borrelia burgdorferi vaccination results in neuropathy

Cornell University - Statistical method to be used by CDC to track HIV risk behavior among drug users

CureVac GmbH - Naked sequence-stabilized mRNA vaccine generates immunity to diverse antigens

Cytos Biotechnology AG - Rapid response of marginal zone B cells to viral particles reported

Drexel University - Peptide-modified alginate surfaces enable re-engineered cells to flourish

Dyax Corp. - Final EDEMA1 results at presented at ACAAI meeting

Dynavax Technologies Corp. - New peanut immunotherapy inhibits allergic response in preclinical studies

EntreMed, Inc. - Cancer/inflammation-focused company reports smaller loss in Q3

Enzon Pharmaceuticals, Inc. - Enzon, partner announce the filing of a new drug submission to Health Canada

Florida State University - Anxiety response linked to drug use

Genaera Corp. - Genaera completes $14.4 million financing

Gilead Sciences, Inc. - European CHMP gives positive opinion on Truvada as part of combo HIV therapy

GlaxoSmithKline - Updated federal guidelines recommend additional first-line therapy for HIV

GlaxoSmithKline Inc. - Absorptive and secretory quotient values for Pgp substrates determined

Greer Laboratories, Inc. - Company receives FDA approval to begin sublingual-oral immunotherapy trial

Hannover Medical School - Self-inactivating vectors outpace those that feature long terminal repeats

Harvard University - Small populations of fit MDRTB strains can out-compete low fitness strains

Harvard University - TCR V beta repertoire directed against influenza CTL epitope reported

Hawaii Department of Health - Airplane measles exposure offers lessons on disease contact response

Henderson Research Center, Ontario - Potential decrease in thromboembolism must be balanced against bleeding risk

Ipsen - OBI-1, recombinant procine Factor VIII, to enter phase II clinical studies

MacroPore Biosurgery, Inc. - Biotech company reports third quarter results

Multiple Sclerosis - U.S. FDA approves new drug to treat multiple sclerosis

Prescription Drugs - Doctors say statin drug should have been pulled sooner

Siemens Medical Solutions - Medical device company introduces CT colonography for enhanced view of polyps

Threshold Pharmaceuticals Inc. - U.S. FDA grants fast track status to glufosfamide for treating pancreatic cancer

Tufts University - Study: Follow-on drugs improve patient safety and help reduce costs

U.S. Centers for Disease Control & Prevention - Economic impact of West Nile virus in Louisiana estimated

U.S. Food & Drug Administration - Methods to inactivate SARS virus described

U.S. Food and Drug Administration - Risk of muscle-damaging disorder low for most commonly prescribed statin drugs

Xillix Technologies Corp. - U.S. FDA accepts Onco-LIFE PMA supplement for filing

Yale University - Immune response allows West Nile easier access to the brain